L’allo-immunisation érythrocytaire fœtomaternelle dans le système ABO reste la principale cause des maladies hémolytiques du fœtus et du nouveau-né. Objectif: Énoncer une directive sur le recours au traitement prophylactique anti-D dans le but d’optimiser la prévention d el’allo-immunisation fœto-maternelle. Prévention de l’allo-immunisation fœto-maternelle Rh: en sommes-nous là? Division de la médecine fœto-maternelle, et présidente associée, Éducation).
|Published (Last):||15 March 2014|
|PDF File Size:||4.19 Mb|
|ePub File Size:||9.3 Mb|
|Price:||Free* [*Free Regsitration Required]|
Early diagnosis and adequate care are necessary to prevent complications in ABO incompatibility.
Intravenous immunoglobulins are used to reduce exchange transfusion. Phototherapy and, in severe cases, exchange transfusion are used to prevent hyperbilirubinemia encephalopathy. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Minon bJ. However, despite a great deal of progress, we should not loose sight of the fact that these tests give only an indirect measurement and will only help the obstetrician, in conjunction with other fetal parameters, to assess the severity of the haemolytic disease HD of the fetus and newborn. Transfert des anticorps maternels vers le foetus. Outline Masquer le plan. Personal information regarding our website’s visitors, including their identity, is confidential.
The best method to assess the severity is the direct determination of foetal blood group hemoglobin after foetal blood sampling but this procedure is not without risk.
We report on alll cases showing that ABO allo-immunization can lead to severe hemolytic disease of the newborn with potentially threatening hyperbilirubinemia and complications. A direct antiglobulin test is the cornerstone of diagnosis and should be performed at birth on alo blood sampling in all group infants born to O mothers, especially if of African origin.
Since 10 years ago, it is possible to determine the RHD genotype of the fetus using amniocytes and, today, maternal plasma directly.
Suivi de l’allo-immunisation foeto-maternelle – EM|consulte
Treatments of severe hemolytic disease of the newborn should be provided and performed by trained personnel in neonatal intensive care units. As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
Access to the text HTML. As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
Contact Help Who are we?
Intensity is generally lower than in RhD allo-immunization. Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care.
No 133-Prévention de l’allo-immunisation fœto-maternelle Rh.
If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Journal page Archives Contents list.
Every newborn should be assessed for the risk of developing severe hyperbilirubinemia and should be examined by a qualified healthcare professional in the first days of life.
Risk factor analysis and attentive clinical monitoring during the first days of life are essential.
There was a problem providing the content you requested
Access to the PDF text. Contact Help Who are we? Top of the page – Article Outline.
Vigilance is even more important for infants discharged before the age of 72 h. You can move this window by clicking on the headline. Immunohaematological tests used in antenatal patients have come a long way.
No Prévention de l’allo-immunisation fœto-maternelle Rh.
Access to the text HTML. Journal page Archives Contents list. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted. If you are a subscriber, please sign in ‘My Account’ at the top foetto of the screen. Qllo to the full text of this article requires a subscription. Access to the full text of this article requires a subscription.